Latest news
REPL Stock Clocks Worst Day In Over 3 Months — New FDA Documents Leave Wall Street Awaiting Another Rejection For Cancer Drug - StocktwitsStocktwits · Sat, 08 Aug 2026 14:11:58 GMTNBIS Stock Wobbles After 50% Rally In 5 Days – But Analysts Still Back AI Infra Plays - StocktwitsStocktwits · Sat, 08 Aug 2026 12:34:47 GMTReplimune’s First Commercial Drug Arrives—With A 2027 Cash Cliff And 2030 Finish Line - StocktwitsStocktwits · Sat, 08 Aug 2026 06:00:23 GMTWhy Is REPL Stock Soaring 127% After Hours Today? - StocktwitsStocktwits · Sat, 08 Aug 2026 04:42:54 GMTREPL Vs IOVA: FDA Decision Day Could Test Biotech Bulls’ Conviction On These Melanoma Plays - StocktwitsStocktwits · Sat, 08 Aug 2026 03:13:33 GMTREPL Stock Slumps 11% After-Hours — What’s Driving The Selloff? - StocktwitsStocktwits · Sat, 08 Aug 2026 02:51:33 GMTIOVA Stock Slump Takes Wall Street, Retail By Surprise — Here’s Why - StocktwitsStocktwits · Fri, 07 Aug 2026 19:41:28 GMTReplimune’s Melanoma FDA Decision Pending: This Analyst Sees 40% Upside, ‘High Conviction’ For Approval - StocktwitsStocktwits · Fri, 07 Aug 2026 09:30:26 GMT